05/14/2025
6:08 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
4:48 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:49 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:50 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:50 PM | Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:51 PM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:52 PM | Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
6:11 AM | Lexicon Pharmaceuticals (Filer)
| Form ARS | |
04/22/2025
6:07 AM | Lexicon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2025
6:09 AM | Lexicon Pharmaceuticals (Filer)
| Form DEFA14A | |
03/28/2025
6:59 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for LXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/03/2025
3:31 PM | Granowitz Craig B (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:32 PM | Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:33 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:33 PM | Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:08 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:04 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:06 PM | Coiante Scott M (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:00 PM | Artal Participations S.a r.l. (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2024
8:33 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/02/2024
4:40 PM | Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/02/2024
4:41 PM | Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:05 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
6:12 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
3:37 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
3:58 PM | DeFrancesco Lisa (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
5:51 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Lexicon Pharmaceuticals (Filer)
| Form EFFECT | |
08/15/2024
3:47 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
7:39 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
7:40 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
8:37 AM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/02/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
4:44 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/29/2024
4:31 PM | Invus Global Management, LLC (Reporting)
Lexicon Pharmaceuticals (Issuer)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
9:10 AM | FMR LLC (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G | |
07/08/2024
4:26 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
4:27 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
4:27 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
8:15 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon just did WHAT!? (Ad) As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC.
Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever.
But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs…
Paving the way for Elon Musk's secret master plan. Click here to see how to claim your stake before they launch to avoid missing out. |
